FR2876688B1 - Nouveau produit, procede et intermediaires de preparation de derives d'azetidine - Google Patents

Nouveau produit, procede et intermediaires de preparation de derives d'azetidine

Info

Publication number
FR2876688B1
FR2876688B1 FR0410844A FR0410844A FR2876688B1 FR 2876688 B1 FR2876688 B1 FR 2876688B1 FR 0410844 A FR0410844 A FR 0410844A FR 0410844 A FR0410844 A FR 0410844A FR 2876688 B1 FR2876688 B1 FR 2876688B1
Authority
FR
France
Prior art keywords
intermediates
new product
azetidine derivatives
preparing azetidine
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0410844A
Other languages
English (en)
Other versions
FR2876688A1 (fr
Inventor
Stephane Mutti
Michel Lavigne
Luc Grondard
Joel Malpart
Zapp Joerg Rieke
Veronique Crocq
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0410844A priority Critical patent/FR2876688B1/fr
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Priority to CA002583992A priority patent/CA2583992A1/fr
Priority to JP2007536214A priority patent/JP2008516932A/ja
Priority to KR1020077008461A priority patent/KR20070063544A/ko
Priority to PCT/FR2005/002490 priority patent/WO2006040465A2/fr
Priority to SG200905236-6A priority patent/SG155193A1/en
Priority to ZA200702528A priority patent/ZA200702528B/xx
Priority to MX2007003923A priority patent/MX2007003923A/es
Priority to EP05809232A priority patent/EP1805167A2/fr
Priority to CNA2005800350837A priority patent/CN101039931A/zh
Priority to AU2005293454A priority patent/AU2005293454A1/en
Priority to BRPI0516507-5A priority patent/BRPI0516507A/pt
Priority to EA200700840A priority patent/EA011408B1/ru
Priority to TW094135607A priority patent/TW200630358A/zh
Priority to ARP050104296A priority patent/AR051390A1/es
Publication of FR2876688A1 publication Critical patent/FR2876688A1/fr
Priority to IL181904A priority patent/IL181904A0/en
Application granted granted Critical
Priority to TNP2007000097A priority patent/TNSN07097A1/fr
Publication of FR2876688B1 publication Critical patent/FR2876688B1/fr
Priority to EC2007007332A priority patent/ECSP077332A/es
Priority to US11/689,588 priority patent/US7687493B2/en
Priority to NO20072192A priority patent/NO20072192L/no
Priority to MA29896A priority patent/MA29513B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0410844A 2004-10-14 2004-10-14 Nouveau produit, procede et intermediaires de preparation de derives d'azetidine Expired - Fee Related FR2876688B1 (fr)

Priority Applications (21)

Application Number Priority Date Filing Date Title
FR0410844A FR2876688B1 (fr) 2004-10-14 2004-10-14 Nouveau produit, procede et intermediaires de preparation de derives d'azetidine
EP05809232A EP1805167A2 (fr) 2004-10-14 2005-10-10 Nouveau produit, procede et intermediaires de preparation de derives d'azetidine
JP2007536214A JP2008516932A (ja) 2004-10-14 2005-10-10 アゼチジン誘導体調製のための新規な生成物、方法および中間体
PCT/FR2005/002490 WO2006040465A2 (fr) 2004-10-14 2005-10-10 Nouveau produit, procede et intermediaires de preparation de derives d'azetidine
BRPI0516507-5A BRPI0516507A (pt) 2004-10-14 2005-10-10 produto, processo e intermediários de preparação de derivados de azetidina
ZA200702528A ZA200702528B (en) 2004-10-14 2005-10-10 Novel product, method and intermediates for the preparation of azetidine derivatives
MX2007003923A MX2007003923A (es) 2004-10-14 2005-10-10 Nuevo producto, procedimiento e intermediarios de preparacion de derivados de azetidina.
SG200905236-6A SG155193A1 (en) 2004-10-14 2005-10-10 Novel product, method and intermediates for the preparation of azetidine derivatives
CNA2005800350837A CN101039931A (zh) 2004-10-14 2005-10-10 新型产品，用于制备吖丁啶衍生物的方法和中间体
AU2005293454A AU2005293454A1 (en) 2004-10-14 2005-10-10 Novel product, method and intermediates for the preparation of azetidine derivatives
CA002583992A CA2583992A1 (fr) 2004-10-14 2005-10-10 Nouveau produit, procede et intermediaires de preparation de derives d'azetidine
EA200700840A EA011408B1 (ru) 2004-10-14 2005-10-10 Новый продукт, способ и промежуточные продукты получения производных азетидина
KR1020077008461A KR20070063544A (ko) 2004-10-14 2005-10-10 아제티딘 유도체를 제조하기 위한 신규한 생성물, 방법 및중간체
ARP050104296A AR051390A1 (es) 2004-10-14 2005-10-13 Derivados de azetidina, pro
TW094135607A TW200630358A (en) 2004-10-14 2005-10-13 Novel product, process and intermediates for preparing azetiding derivatives
IL181904A IL181904A0 (en) 2004-10-14 2007-03-13 Novel product, method and intermediates for the preparation of azetidine derivatives
TNP2007000097A TNSN07097A1 (fr) 2004-10-14 2007-03-16 Nouveau produit, procede et intermediaires de preparation de derives d'azetidine
EC2007007332A ECSP077332A (es) 2004-10-14 2007-03-21 Nuevo producto, procedimiento e intermediarios de preparación de derivados de azetidina
US11/689,588 US7687493B2 (en) 2004-10-14 2007-03-22 Product, method and intermediates for the preparation of azetidine derivatives
NO20072192A NO20072192L (no) 2004-10-14 2007-04-27 Nytt produkt, fremgangsmate og mellomprodukter for fremstilling av azetidinderivater
MA29896A MA29513B1 (fr) 2004-10-14 2007-05-11 Nouveau produit, procede et intermediaires de preparation de derives d'azetidine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0410844A FR2876688B1 (fr) 2004-10-14 2004-10-14 Nouveau produit, procede et intermediaires de preparation de derives d'azetidine

Publications (2)

Publication Number Publication Date
FR2876688A1 FR2876688A1 (fr) 2006-04-21
FR2876688B1 true FR2876688B1 (fr) 2007-03-16

Family

ID=34954419

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0410844A Expired - Fee Related FR2876688B1 (fr) 2004-10-14 2004-10-14 Nouveau produit, procede et intermediaires de preparation de derives d'azetidine

Country Status (21)

Country Link
US (1) US7687493B2 (fr)
EP (1) EP1805167A2 (fr)
JP (1) JP2008516932A (fr)
KR (1) KR20070063544A (fr)
CN (1) CN101039931A (fr)
AR (1) AR051390A1 (fr)
AU (1) AU2005293454A1 (fr)
BR (1) BRPI0516507A (fr)
CA (1) CA2583992A1 (fr)
EA (1) EA011408B1 (fr)
EC (1) ECSP077332A (fr)
FR (1) FR2876688B1 (fr)
IL (1) IL181904A0 (fr)
MA (1) MA29513B1 (fr)
MX (1) MX2007003923A (fr)
NO (1) NO20072192L (fr)
SG (1) SG155193A1 (fr)
TN (1) TNSN07097A1 (fr)
TW (1) TW200630358A (fr)
WO (1) WO2006040465A2 (fr)
ZA (1) ZA200702528B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113045539B (zh) * 2021-03-30 2021-12-07 苏州大学 2-(4,4-二氯-1-(8-喹啉基)-2-氮杂环丁基)羧酸酯衍生物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8709887D0 (en) * 1987-04-27 1987-06-03 Univ Alberta Alkyl azodicarboxylates
US5530134A (en) * 1994-09-06 1996-06-25 Synphar Laboratories Inc. Synthesis of anabaseine, salts and derivatives thereof
FR2805817B1 (fr) * 2000-03-03 2002-04-26 Aventis Pharma Sa Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
US6355631B1 (en) * 2000-03-03 2002-03-12 Aventis Pharma S.A. Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation
AU7775401A (en) * 2000-08-10 2002-02-25 Welfide Corp Proline derivatives and use thereof as drugs
CN101407471A (zh) * 2003-08-29 2009-04-15 小野药品工业株式会社 能够结合s1p受体的化合物及其药物用途

Also Published As

Publication number Publication date
AU2005293454A1 (en) 2006-04-20
FR2876688A1 (fr) 2006-04-21
SG155193A1 (en) 2009-09-30
MA29513B1 (fr) 2008-06-02
KR20070063544A (ko) 2007-06-19
CA2583992A1 (fr) 2006-04-20
TW200630358A (en) 2006-09-01
US20070270463A1 (en) 2007-11-22
IL181904A0 (en) 2007-07-04
US7687493B2 (en) 2010-03-30
NO20072192L (no) 2007-04-27
EP1805167A2 (fr) 2007-07-11
AR051390A1 (es) 2007-01-10
EA200700840A1 (ru) 2007-08-31
EA011408B1 (ru) 2009-02-27
ECSP077332A (es) 2007-04-26
WO2006040465A3 (fr) 2006-08-10
TNSN07097A1 (fr) 2008-06-02
WO2006040465A2 (fr) 2006-04-20
CN101039931A (zh) 2007-09-19
BRPI0516507A (pt) 2008-09-16
JP2008516932A (ja) 2008-05-22
MX2007003923A (es) 2007-06-07
ZA200702528B (en) 2008-07-30

Similar Documents

Publication Publication Date Title
EP1619199A4 (fr) Derives de glycolipide, leur procede de production, intermediaires pour la synthese associee, et procede de production desdits intermediaires
FR2889030B1 (fr) Produit alimentaire multicouche et procede pour sa preparation
FR2866335B1 (fr) Nouveau procede de synthese de l'agomelatine
FR2904311B1 (fr) Nouveau procede de synthese de derives (e) stilbeniques perm permettant d'obtenir le resveratrol et le piceatannol
EP1755550A4 (fr) Appareil de rotation pour lits de culture de produits agricoles
FR2871793B1 (fr) Procede de production d'une poudre d'alpha-alumine
HUP0304101A3 (en) Pyrazole derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates
FR2883876B1 (fr) Derives d'indanyl-piperazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2855166B1 (fr) Procede de production d'une poudre d'alpha-alumine
FR2881138B1 (fr) Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2852012B1 (fr) Procede de preparation de derives o-acyles du glucose
FR2889530B1 (fr) Produit issu d'un extrait proteinique de guar, procede de preparation et utilisations
IL175834A (en) Process and intermediates for producing (3-oxo-2,3-dihydro-1h-isoindol-1-yl) acetylguanidine derivatives, some novel salts thereof and their use for production of medicaments
FR2876688B1 (fr) Nouveau produit, procede et intermediaires de preparation de derives d'azetidine
FR2940650B1 (fr) Nouveaux derives d'oxime du 3,5-seco-4-nor-cholestane, compositions pharmaceutiques les renfermant,et procede de preparation
FR2939431B1 (fr) Procede de production d'un produit intermediaire destine a la production d'ethanol, et produit intermediaire obtenu.
FR2882357B1 (fr) Utilisation de derives de phenanthrenes en tant qu'agents anti-inflammatoires, procede de synthese et produits intermediaires
TNSN07115A1 (fr) Procede et intermediaires de preparation de derives de n-(1-benzhydryl-azetidin-3-yl)-n-phenyl-methylsulfonamide
FR2841561B1 (fr) Produit bitumineux et son procede de preparation
HUP0500877A2 (en) Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use and intermediates
HUP0500879A2 (en) Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use and intermediates
FR2907316B1 (fr) Procede de preparation d'un produit alimentaire a bords scelles et produit alimentaire a bords scelles obtenu selon ce procede
FR2881137B1 (fr) Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2854623B1 (fr) Aquo-oxo chlorure de titane, procede pour sa preparation
FR2865901B1 (fr) Procede de preparation d'un produit alimentaire semi-fluide

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20110630